A tiny implant tested in Boston is providing a groundbreaking treatment for macular telangiectasia, a rare eye disease, by slowing or stopping its progression.
A tiny implant tested in Boston is providing a groundbreaking treatment for macular telangiectasia, a rare eye disease, by slowing or stopping its progression.
